Sofinnova Investments as of Sept. 30, 2024
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 58 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera (NTRA) | 15.6 | $197M | 1.6M | 126.95 | |
| Vera Therapeutics Cl A (VERA) | 9.8 | $124M | 2.8M | 44.20 | |
| Novo-Nordisk A S Adr (NVO) | 6.9 | $87M | 726k | 119.07 | |
| AstraZeneca Sponsored Adr (AZN) | 5.0 | $63M | 809k | 77.91 | |
| Ideaya Biosciences (IDYA) | 4.4 | $55M | 1.7M | 31.68 | |
| Elanco Animal Health (ELAN) | 4.1 | $52M | 3.5M | 14.69 | |
| Bioage Labs (BIOA) | 3.8 | $48M | 2.3M | 20.80 | |
| Axsome Therapeutics Put Option (AXSM) | 3.8 | $48M | 530k | 89.87 | |
| Incyte Corporation (INCY) | 3.7 | $47M | 714k | 66.10 | |
| Soleno Therapeutics (SLNO) | 3.6 | $45M | 886k | 50.49 | |
| Rapport Therapeutics (RAPP) | 3.2 | $41M | 2.0M | 20.48 | |
| Arrivent Biopharma (AVBP) | 3.2 | $40M | 1.7M | 23.50 | |
| Y Mabs Therapeutics | 2.3 | $29M | 2.2M | 13.15 | |
| Dyne Therapeutics (DYN) | 2.2 | $28M | 772k | 35.92 | |
| Cogent Biosciences (COGT) | 1.9 | $25M | 2.3M | 10.80 | |
| Savara (SVRA) | 1.9 | $24M | 5.7M | 4.24 | |
| Novartis Sponsored Adr Put Option (NVS) | 1.8 | $23M | 200k | 115.02 | |
| Inozyme Pharma (INZY) | 1.8 | $22M | 4.3M | 5.23 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.7 | $21M | 189k | 111.41 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $21M | 286k | 73.00 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $15M | 787k | 19.25 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $15M | 277k | 52.39 | |
| Edwards Lifesciences (EW) | 1.1 | $13M | 203k | 65.99 | |
| Boston Scientific Corporation (BSX) | 0.9 | $11M | 136k | 83.80 | |
| Pharvaris N V (PHVS) | 0.9 | $11M | 600k | 18.52 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $10M | 385k | 26.69 | |
| Immunome (IMNM) | 0.8 | $9.9M | 677k | 14.62 | |
| Guardant Health (GH) | 0.7 | $9.3M | 407k | 22.94 | |
| Revolution Medicines (RVMD) | 0.7 | $9.2M | 203k | 45.35 | |
| Inhibrx Biosciences (INBX) | 0.7 | $8.4M | 536k | 15.66 | |
| Tg Therapeutics (TGTX) | 0.7 | $8.4M | 359k | 23.39 | |
| Aerovate Therapeutics (AVTE) | 0.6 | $7.9M | 3.8M | 2.09 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $7.9M | 182k | 43.27 | |
| Marinus Pharmaceuticals | 0.6 | $7.7M | 4.4M | 1.76 | |
| Janux Therapeutics (JANX) | 0.6 | $7.5M | 165k | 45.43 | |
| Cabaletta Bio (CABA) | 0.6 | $7.2M | 1.5M | 4.72 | |
| Achieve Life Sciences (ACHV) | 0.6 | $7.2M | 1.5M | 4.74 | |
| Kura Oncology (KURA) | 0.5 | $5.8M | 297k | 19.54 | |
| Phibro Animal Health Corp Cl A Com (PAHC) | 0.4 | $5.4M | 238k | 22.52 | |
| Illumina (ILMN) | 0.4 | $5.3M | 41k | 130.41 | |
| Erasca (ERAS) | 0.4 | $5.0M | 1.8M | 2.73 | |
| Immatics SHS (IMTX) | 0.3 | $4.4M | 386k | 11.41 | |
| Inari Medical Ord | 0.3 | $3.7M | 90k | 41.24 | |
| Becton, Dickinson and (BDX) | 0.3 | $3.7M | 15k | 241.10 | |
| Nextcure (NXTC) | 0.3 | $3.7M | 2.7M | 1.37 | |
| Thermo Fisher Scientific (TMO) | 0.3 | $3.6M | 5.8k | 618.57 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $2.6M | 38k | 68.12 | |
| Disc Medicine (IRON) | 0.2 | $2.0M | 41k | 49.14 | |
| Bolt Biotherapeutics | 0.1 | $1.8M | 2.8M | 0.65 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $1.7M | 39k | 43.89 | |
| Perspective Therapeutics (CATX) | 0.1 | $1.6M | 121k | 13.35 | |
| Avidity Biosciences Ord (RNA) | 0.1 | $1.4M | 31k | 45.93 | |
| Vir Biotechnology (VIR) | 0.1 | $968k | 129k | 7.49 | |
| Astria Therapeutics (ATXS) | 0.1 | $943k | 86k | 11.01 | |
| Immatics *w Exp 07/01/2025 (IMTXW) | 0.1 | $852k | 367k | 2.33 | |
| Ikena Oncology (IKNA) | 0.1 | $662k | 383k | 1.73 | |
| Replimune Group (REPL) | 0.0 | $528k | 48k | 10.96 | |
| Pulmonx Corp (LUNG) | 0.0 | $517k | 62k | 8.29 |
